Bender Robert & Associates Illumina, Inc. Transaction History

Bender Robert & Associates

  • $471 Million
  • Q3 2024

A detailed history of Bender Robert & Associates transactions in Illumina, Inc. stock. As of the latest transaction made, Bender Robert & Associates holds 44,579 shares of ILMN stock, worth $6.06 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
44,579
Previous 44,961 0.85%
Holding current value
$6.06 Million
Previous $4.69 Million 23.87%
% of portfolio
1.23%
Previous 1.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$105.28 - $135.9 $4.69 Million - $6.06 Million
44,579 New
44,579 $5.81 Million
Q1 2024

Apr 22, 2024
SELL
$127.73 - $147.2 $22,225 - $25,612
-174 Reduced 0.38%
45,990 $6.32 Million
Q4 2023

Jan 31, 2024
SELL
$92.79 - $142.53 $98,450 - $151,224
-1,061 Reduced 2.25%
46,164 $6.43 Million
Q3 2023

Oct 13, 2023
SELL
$128.91 - $192.44 $89,205 - $133,168
-692 Reduced 1.44%
47,225 $6.48 Million
Q2 2023

Jul 13, 2023
SELL
$183.43 - $232.67 $349,984 - $443,934
-1,908 Reduced 3.83%
47,917 $8.98 Million
Q1 2023

Apr 20, 2023
SELL
$193.75 - $232.55 $102,493 - $123,018
-529 Reduced 1.05%
49,825 $11.6 Million
Q4 2022

Feb 02, 2023
SELL
$187.24 - $242.74 $159,715 - $207,057
-853 Reduced 1.67%
50,354 $10.2 Million
Q3 2022

Oct 26, 2022
BUY
$177.23 - $227.44 $313,165 - $401,886
1,767 Added 3.57%
51,207 $9.77 Million
Q2 2022

Jul 19, 2022
SELL
$181.58 - $368.0 $90,245 - $182,896
-497 Reduced 1.0%
49,440 $9.12 Million
Q1 2022

Apr 14, 2022
BUY
$303.87 - $423.8 $108,785 - $151,720
358 Added 0.72%
49,937 $17.4 Million
Q3 2021

Nov 09, 2021
BUY
$405.61 - $524.84 $19.9 Million - $25.8 Million
49,074 Added 9717.62%
49,579 $20.1 Million
Q3 2021

Nov 03, 2021
SELL
$405.61 - $524.84 $19.9 Million - $25.8 Million
-49,091 Reduced 98.98%
505 $314,000
Q2 2021

Jul 16, 2021
BUY
$372.84 - $481.5 $102,531 - $132,412
275 Added 0.56%
49,596 $23.5 Million
Q1 2021

Apr 28, 2021
BUY
$361.28 - $504.76 $179,917 - $251,370
498 Added 1.02%
49,321 $18.9 Million
Q4 2020

Jan 29, 2021
BUY
$292.7 - $370.96 $54,734 - $69,369
187 Added 0.38%
48,823 $18.1 Million
Q3 2020

Oct 29, 2020
SELL
$268.51 - $400.74 $98,543 - $147,071
-367 Reduced 0.75%
48,636 $15 Million
Q2 2020

Jul 31, 2020
SELL
$256.46 - $373.01 $104,892 - $152,561
-409 Reduced 0.83%
49,003 $18.1 Million
Q1 2020

Apr 21, 2020
SELL
$209.2 - $335.53 $33,053 - $53,013
-158 Reduced 0.32%
49,412 $13.5 Million
Q4 2019

Jan 31, 2020
SELL
$288.29 - $335.49 $148,469 - $172,777
-515 Reduced 1.03%
49,570 $16.4 Million
Q3 2019

Oct 15, 2019
SELL
$266.84 - $378.23 $81,919 - $116,116
-307 Reduced 0.61%
50,085 $15.2 Million
Q2 2019

Jul 30, 2019
SELL
$300.59 - $368.15 $244,379 - $299,305
-813 Reduced 1.59%
50,392 $15.2 Million
Q1 2019

Apr 30, 2019
SELL
$272.57 - $321.18 $82,861 - $97,638
-304 Reduced 0.59%
51,205 $15.9 Million
Q4 2018

Jan 24, 2019
SELL
$272.46 - $366.54 $246,303 - $331,352
-904 Reduced 1.72%
51,509 $15.4 Million
Q3 2018

Oct 17, 2018
SELL
$279.04 - $367.06 $63,342 - $83,322
-227 Reduced 0.43%
52,413 $19.2 Million
Q2 2018

Jul 27, 2018
BUY
$228.17 - $292.07 $12,777 - $16,355
56 Added 0.11%
52,640 $14.7 Million
Q1 2018

Apr 27, 2018
SELL
$209.54 - $253.91 $531,393 - $643,915
-2,536 Reduced 4.6%
52,584 $12.4 Million
Q4 2017

Jan 19, 2018
SELL
$202.23 - $230.03 $71,589 - $81,430
-354 Reduced 0.64%
55,120 $12 Million
Q3 2017

Oct 23, 2017
BUY
$172.3 - $213.93 $9.56 Million - $11.9 Million
55,474
55,474 $11.1 Million

Others Institutions Holding ILMN

# of Institutions
900
Shares Held
137M
Call Options Held
1.22M
Put Options Held
1.43M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Bender Robert & Associates Portfolio

Follow Bender Robert & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Bender Robert & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email